Reaction
Surgical Failure reporting signals
As of the last recalculation, Surgical Failure appears in 1,144 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is ADALIMUMAB (PRR 28.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Adalimumab | 572 | 28.4 | 28.4 |
| Hydroxychloroquine Sulfate | 90 | 19.4 | 19.4 |
| Leflunomide | 88 | 16.5 | 16.5 |
| Dalteparin Sodium | 9 | 15.6 | 15.6 |
| Tocilizumab | 78 | 13.3 | 13.3 |
| Upadacitinib | 49 | 11.4 | 11.4 |
| Abatacept | 75 | 10.5 | 10.5 |
| Risankizumab-Rzaa | 38 | 8.7 | 8.7 |